|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/08 | (2006.01) |
| A61P 31/04 | (2018.01) | ||
| A61K 31/439 | (2006.01) | ||
| C07D 471/08 | (2013.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61K 31/551 | (2013.01) |
| (11) | Patento numeris | 3719020 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18884744.6 |
| Europos patento paraiškos padavimo data | 2018-12-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-10-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-09-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2018/118864 |
| Data | 2018-12-03 |
| (87) | Numeris | WO 2019/105479 |
| Data | 2019-06-06 |
| (30) | Numeris | Data | Šalis |
| 201711251386 | 2017-12-01 | CN |
| (72) |
LI, Cheng , CN
HUANG, Zhigang , CN
DING, Charles Z. , CN
LI, Weidong , CN
|
| (73) |
QILU PHARMACEUTICAL CO., LTD. ,
No. 317, Xinluo Street, High Technical Zone Jinan
Shandong 250100,
CN
|
| (54) | CRYSTAL FORM OF BETA-LACTAMASE INHIBITOR AND PREPARATION METHOD THEREFOR |
| CRYSTAL FORM OF BETA-LACTAMASE INHIBITOR AND PREPARATION METHOD THEREFOR |